MedTech Acquisition Corporation (MTAC)
|Net Income (ttm)||n/a|
|Trading Day||April 19|
|Day's Range||9.73 - 9.88|
|52-Week Range||9.45 - 11.18|
MedTech Acquisition Corporation Announces Separate Trading of its Class A Common Stock and Warrants, Commencing Febru...
New York, NY, Feb. 05, 2021 (GLOBE NEWSWIRE) -- MedTech Acquisition Corporation (Nasdaq:MTACU) (the “Company”) announced today that, commencing February 8, 2021, holders of the 25,000,000 units sold in ...
New York, NY, Dec. 22, 2020 (GLOBE NEWSWIRE) -- MedTech Acquisition Corporation (the “Company”) announced today that it closed its initial public offering of 25,000,000 units, which included 3,000,000 u...
New York, NY, Dec. 17, 2020 (GLOBE NEWSWIRE) -- MedTech Acquisition Corporation (the “Company”) announced today that it priced its upsized initial public offering of 22,000,000 units at $10.00 per unit....
MedTech Acquisition, a blank check company targeting a US medical technology business, filed on Monday with the SEC to raise up to $200 million in an initial public offering.
MedTech Acquisition Corporation has filed to go public with an IPO on the NASDAQ.
Medtech Acquisition is a blank check company whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. We will seek to capitalize on the decades of experience and relationships of our management team, including Karim Karti, our chairman nominee, Christopher C. Dewey, our Chief Executive Officer and director, David J. Matlin, our Chief Financial Officer and director, and Robert H. Weiss, our Chief Administrative Officer and ... [Read more...]
|IPO Date |
Dec 18, 2020
Christopher C. Dewey
|Stock Exchange |
|Ticker Symbol |